Design and implementation of a novel doctor of pharmacy curriculum

Introduction: The University of California San Francisco School of Pharmacy has a rich tradition of transforming curricula to graduate pharmacists who are equipped to serve the current and future healthcare needs of the public. Description of programme: This paper describes the process of the design, build, and implementation of a three-year, year-round, competency-based, integrated, Doctor of Pharmacy curriculum with a pass/no pass grading policy. Evaluation: A variety of data streams are in place to collect data on courses, teaching, and student performance as part of continuous quality improvement activities. Future Plans: In addition to traditional evaluation metrics of the curriculum the school will implement a career outcomes project to track students’ career and employment placements. The results of the evaluation and assessment activities will be shared in future manuscripts.

The impact of weekly multicourse collective exams on pharmacy student academic behaviors and learning in an integrated biological sciences course

Doctor of Pharmacy (PharmD) degree program curricula are typically comprised of heavy course loads and assessment burden. Typically, students “live” from exam to exam only preparing and studying for the exam directly ahead of them while neglecting concurrent courses. Therefore, the aim of the study was to determine the impact of weekly multicourse collective exams academic behaviors and learning in an integrated biological sciences (BSI) course within a PharmD program. Weekly multicourse exams included questions, four per credit hour, from all first semester courses that traditionally included summative exams. Seven courses contributed questions, which amounted to 15 weekly exams of ∼60 questions. No other graded assessments were given in any of the courses, other than individual course cumulative final exams; the final exams in each course were not collective. After completion of final exams, a Qualtrics survey was emailed to all students and the two professors teaching the course. Course grades, not including the final exam, were compared between two cohorts with or without the collective exams to determine impact on learning. The cumulative final exam was compared between cohorts to determine impact on retention. The majority of students agreed or strongly agreed that the weekly collective exams encouraged them to study BSI more frequently, most days of the week, reduced the likelihood of skipping class, and increased likelihood to pay attention and engage in class. The majority believed that they better learned and retained the BSI material. The majority specified that they liked the collective exams for BSI and preferred it over a traditional exam schedule. Learning also appeared to be improved. However, the impact on retention is less clear and requires further research. In conclusion, the weekly multicourse collective exams improved academic behaviors and learning.

Accessibility of postgraduate training program information to graduates from US doctor of pharmacy programs holding F-1 visas

Disclaimer In an effort to expedite the publication of articles , AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose To evaluate information provided by residency and fellowship programs to graduates of Accreditation Council for Pharmacy Education–accredited doctor of pharmacy programs holding F-1 visas who are seeking postgraduate training opportunities. Methods A 2-phase review of all US-based postgraduate year 1 (PGY1) residency and fellowship programs was conducted. In phase 1, program eligibility criteria were reviewed from the residency and fellowship directories published by the American Society of Health-System Pharmacists (ASHP) and American College of Clinical Pharmacy (ACCP). In phase 2, the postgraduate programs’ official websites were reviewed for additional information. Each program was evaluated to determine the eligibility of international students with F-1 visa or Optional Practical Training (OPT) status, visa sponsorship and work authorization opportunities, and citizenship requirements. Programs were classified as eligible or noneligible to international students or as not providing sufficient information. Descriptive statistics were used to summarize the data. Results A total of 1,455 ASHP PGY1 programs and 69 fellowship programs were included in our analysis. In phase 1, there were 3 eligible programs accepting applicants with F-1/OPT status and 377 noneligible programs. In phase 2, there were 10 eligible programs accepting applicants with F-1/OPT status or providing H-1B sponsorship and 410 noneligible programs. Over 70% of programs (phase 1, n = 1,075; phase 2, n = 1,035) were classified as providing no information. None of the fellowship programs were classified as eligible in our review. Conclusion Most residency and fellowship programs did not provide clear eligibility criteria for students with F-1/OPT status. Only a few programs clearly stated that they would accept applicants with F-1/OPT status or provide visa sponsorship to graduates holding F-1 visas.